Adgero Biopharmaceuticals Holdings, Inc.
Pharmaceutical company · Princeton, New Jersey, United States
Adgero Biopharmaceuticals Holdings, Inc. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $459,000 sold in a notice filed in 2016.
Adgero Biopharmaceuticals Holdings at a glance
What does Adgero Biopharmaceuticals Holdings do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $459,000 sold (2016).
Frequently asked questions about Adgero Biopharmaceuticals Holdings
Where is Adgero Biopharmaceuticals Holdings headquartered?
Adgero Biopharmaceuticals Holdings, Inc. is headquartered in Princeton, New Jersey, United States.
What does Adgero Biopharmaceuticals Holdings do?
Adgero Biopharmaceuticals Holdings, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Adgero Biopharmaceuticals Holdings founded?
The earliest incorporation on record for Adgero Biopharmaceuticals Holdings, Inc. is in 2015, according to public company registers.
Similar companies
- Soligenix, Inc.Princeton, New Jersey, United States
- PDS Biotechnology CorpPrinceton, New Jersey, United States
- Enalare Therapeutics Inc.Princeton, New Jersey, United States
- Amicus Therapeutics, Inc.Princeton, New Jersey, United States
- Bristol Myers Squibb CoPrinceton, New Jersey, United States
- Grace Therapeutics, Inc.Princeton, New Jersey, United States
- PMV Pharmaceuticals, Inc.Princeton, New Jersey, United States
- Church & Dwight Co., Inc.Princeton, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences